Senior Research Scientist, Regenerative Medicine RxGen, Inc.
Biography
Dr. Wakeman's primary research goals are directed at determining the long-term value of stem cell-based therapeutics for regenerative medicine. His past work using dopamine neurons derived from pluripotent stem cells, both human embryonic stem cells and induced pluripotent stem cells (iPSC), as a cell based strategy for dopamine replacement in animal models of Parkinson's disease has consistently supported therapeutic value moving toward the clinic. Dr. Wakeman recently joined RxGen, Inc., a translational therapeutics and disease modeling company, where he is applying his expertise and experience in regenerative medicine to bridge the translational research gap using primate models of human disease. Dr. Wakeman also holds an Adjunct Assistant Professor position in the Department of Psychiatry at Yale School of Medicine.